It would therefore be of great interest to follow glucose regulation in a larger cohort of Rubistein-Taybi syndrome patients with specific p300 mutations to further ascertain association between p300 loss and diabetes-like phenotypes in humans. The gene discussed is EP300; the disease is diabetes mellitus.